On December 19, Morgan Stanley analyst Jeffrey Hung downgraded PTC Therapeutics, Inc. (NASDAQ:PTCT) from Equalweight to Underweight, within the biotechnology industry.

Keep Reading →

December 20th, 2023 - News

PTC Therapeutics, Inc. (NASDAQ:PTCT) Q3 2023 Earnings Call Transcript

Operator: Thank you for standing by and welcome to the PTC Therapeutics Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

October 30th, 2023 - News Transcripts

PTC Therapeutics (PTCT) Lost 16% in Q2

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter investor letter. A copy of the same can be downloaded here.

Keep Reading →

September 25th, 2023 - Hedge Fund Investor Letters News

Analysts on Wall Street Lower Ratings for These 5 Stocks

Federal Realty Investment Trust (NYSE:FRT) is a leading real estate company specializing in high-quality retail properties in major coastal markets from Washington, D.C., to Boston, San Francisco, and...

Keep Reading →

September 19th, 2023 - Market Movers News

PTC Therapeutics, Inc. (NASDAQ:PTCT) Q2 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by and welcome to the PTC Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

August 4th, 2023 - News Transcripts

PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by and welcome to the PTC First Quarter 2023 Financial Results Call. All participants are in a listen-only mode.

Keep Reading →

May 4th, 2023 - News Transcripts